Odeon Capital analyst Dick Bove upgrades Wells Fargo (NYSE:WFC) from Hold to Buy.
FDA Questions Kaleido Biosciences ‘Non-IND’ COVID-19 Trial
The FDA has issued a warning letter to Kaleido Biosciences Inc (NASDAQ:KLDO), blasting its “failure to submit Investigational New Drug applications for…